| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.FPC.0000184959.82903.02 |
| P698 | PubMed publication ID | 16344724 |
| P50 | author | Qian Tao | Q57795670 |
| P2093 | author name string | Richie Soong | |
| Soo-Chin Lee | |||
| Boon-Cher Goh | |||
| Seng-Gee Lim | |||
| Jia-Yi Guo | |||
| Ross Soo | |||
| Thomas Putti | |||
| Wen-Son Hsieh | |||
| P433 | issue | 1 | |
| P304 | page(s) | 73-74 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Pharmacogenetics and Genomics | Q10534561 |
| P1476 | title | Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma | |
| P478 | volume | 16 |
| Q33265633 | A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma |
| Q39869486 | Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays |
| Q37798817 | Developing better treatments in hepatocellular carcinoma |
| Q26771265 | EGFR Signaling in Liver Diseases |
| Q44449930 | ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma |
| Q34566972 | Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients |
| Q36729450 | HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. |
| Q90448494 | HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant |
| Q36766842 | In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma |
| Q38690528 | Investigational drugs for nasopharyngeal carcinoma |
| Q36382083 | Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis |
| Q40467961 | Missense Mutations in Exons 18-24 of EGFR in Hepatocellular Carcinoma Tissues. |
| Q36121338 | Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma |
| Q39431960 | Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways |
| Q37982126 | Novel systemic therapeutic for nasopharyngeal carcinoma. |
| Q37660226 | Oncogene mutational profile in nasopharyngeal carcinoma |
| Q55065500 | Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy. |
| Q90053595 | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board |
| Q40564800 | SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor. |
| Q37171008 | Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. |
| Q36613969 | Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer |
| Q35986801 | Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations |
| Q38905388 | Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma |
Search more.